Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRVS |
---|---|---|
09:32 ET | 233 | 2.17 |
09:39 ET | 100 | 2.15 |
09:48 ET | 6400 | 2.13 |
09:50 ET | 210 | 2.1402 |
10:01 ET | 100 | 2.17 |
10:08 ET | 300 | 2.185 |
10:19 ET | 200 | 2.2 |
10:21 ET | 4000 | 2.1999 |
10:24 ET | 200 | 2.205 |
10:28 ET | 500 | 2.1931 |
10:33 ET | 100 | 2.23 |
10:39 ET | 261 | 2.21 |
10:44 ET | 850 | 2.22 |
10:46 ET | 1016 | 2.22 |
10:50 ET | 100 | 2.22 |
10:51 ET | 200 | 2.24 |
10:57 ET | 500 | 2.225 |
11:08 ET | 954 | 2.24 |
11:09 ET | 312 | 2.24 |
11:13 ET | 100 | 2.24 |
11:27 ET | 1051 | 2.26 |
11:31 ET | 100 | 2.255 |
11:33 ET | 306 | 2.27 |
11:36 ET | 510 | 2.27 |
11:38 ET | 300 | 2.28 |
11:40 ET | 231 | 2.28 |
11:42 ET | 575 | 2.271 |
11:44 ET | 646 | 2.2701 |
11:45 ET | 4495 | 2.27 |
11:54 ET | 2200 | 2.24 |
11:56 ET | 5099 | 2.2301 |
11:58 ET | 100 | 2.24 |
12:00 ET | 200 | 2.23 |
12:03 ET | 205 | 2.21 |
12:07 ET | 386 | 2.2255 |
12:12 ET | 3300 | 2.225 |
12:21 ET | 400 | 2.24 |
12:30 ET | 1583 | 2.2 |
12:32 ET | 3400 | 2.1801 |
12:36 ET | 709 | 2.19 |
12:39 ET | 674 | 2.2 |
12:45 ET | 150 | 2.194 |
12:54 ET | 1000 | 2.1833 |
12:59 ET | 3976 | 2.18 |
01:24 ET | 851 | 2.16 |
01:30 ET | 100 | 2.16 |
01:35 ET | 500 | 2.1971 |
01:37 ET | 1000 | 2.1992 |
01:39 ET | 100 | 2.18 |
01:44 ET | 500 | 2.1851 |
01:50 ET | 333 | 2.16 |
01:55 ET | 100 | 2.18 |
01:57 ET | 100 | 2.16 |
02:09 ET | 100 | 2.18 |
02:27 ET | 100 | 2.21 |
02:29 ET | 200 | 2.19 |
02:47 ET | 1200 | 2.21 |
02:49 ET | 100 | 2.195 |
02:54 ET | 500 | 2.2 |
03:00 ET | 100 | 2.22 |
03:02 ET | 200 | 2.22 |
03:05 ET | 200 | 2.22 |
03:07 ET | 1433 | 2.21 |
03:14 ET | 100 | 2.23 |
03:16 ET | 190 | 2.22 |
03:20 ET | 100 | 2.23 |
03:21 ET | 490 | 2.21 |
03:23 ET | 2000 | 2.18 |
03:25 ET | 200 | 2.185 |
03:27 ET | 2500 | 2.2096 |
03:30 ET | 100 | 2.19 |
03:32 ET | 400 | 2.21 |
03:34 ET | 400 | 2.18 |
03:36 ET | 100 | 2.21 |
03:38 ET | 200 | 2.22 |
03:39 ET | 497 | 2.21 |
03:41 ET | 6861 | 2.22 |
03:45 ET | 300 | 2.22 |
03:48 ET | 100 | 2.22 |
03:52 ET | 574 | 2.23 |
03:54 ET | 100 | 2.22 |
03:56 ET | 2345 | 2.21 |
03:57 ET | 305 | 2.2 |
03:59 ET | 1376 | 2.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corvus Pharmaceuticals Inc | 135.1M | -4.3x | --- |
Tevogen Bio Holdings Inc | 134.1M | -1,806.5x | --- |
Gossamer Bio Inc | 133.5M | -0.5x | --- |
RAPT Therapeutics Inc | 139.5M | -1.4x | --- |
Citius Pharmaceuticals Inc | 126.0M | -2.7x | --- |
Cardiff Oncology Inc | 142.2M | -3.3x | --- |
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitinib, a selective, covalent inhibitor of ITK (interleukin 2 inducible T cell kinase) and is in a multi-center Phase 1/1b clinical trial in patients with various recurrent, malignant T cell lymphomas. Soquelitinib is designed to inhibit the proliferation of certain malignant T cells. Its second product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine designed to disable a tumor’s ability to subvert attack by the immune system by blocking the binding of immunosuppressive adenosine in the tumor microenvironment to the A2A receptor. The Company’s third product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $135.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 62.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.10 |
EPS | $-0.51 |
Book Value | $0.79 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.